Eli Lilly €1.8 billion and £250 million notes offering
The investment-grade offering included the company’s inaugural sustainability bonds
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Maravai LifeSciences $1 billion secondary offering
The shares are listed on the Nasdaq Global Select Market
PerkinElmer $2.3 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
MultiPlan $1.05 billion notes offering and $1.775 billion credit facility
We advised the initial purchasers on the secured high-yield debt offering and the lead arrangers on the new credit agreement
Triple-S Management $900 million acquisition by GuideWell
We are advising Triple-S on the transaction
Kora Saúde R$770 million IPO
We advised the joint bookrunners on the IPO and São Paulo Stock Exchange listing
Adagio Therapeutics $356 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Viveo R$1.9 billion IPO
We advised Viveo and the selling shareholders on its IPO and São Paulo Stock Exchange listing
LivaNova $345 million equity offering
We advised the underwriters on the SEC-registered offering
Nurix Therapeutics $150 million at-the-market offering
We advised the sales agent on the stock offering